Given that XRCC1 and APE1 depletion sensitized colon cancer cells to FdUrd, and that PARP plays a key role in BER, we reasoned that PARP inhibitors may sensitize colon cancer cells to FdUrd. The gene discussed is APEX1; the disease is colonic neoplasm.